Dennis has extensive experience developing and operating businesses across pharmaceuticals, consumer health and pharmacy retailing and wholesaling. He is currently the Executive Chairman and CEO of DBG Health, Australia’s largest diversified pharmaceutical, health and beauty products business.
In 2015 Dennis along with partner Strides Pharmaceuticals, acquired the Arrow business from Aspen Pharmaceuticals. After buying out the Strides ownership in Arrow Pharmaceuticals in 2019, he merged the business with Apotex Australia to form Arrotex Pharmaceuticals. In 2023 Dennis acquired full ownership of Arrotex Pharmaceuticals, Juno Pharmaceuticals and Axe Health to form DBG Health.
Prior to this, Dennis founded Ascent Pharmaceuticals in 2003 and as CEO went on to build his first successful generic pharmaceutical company which was ultimately sold to Actavis Pharmaceuticals in 2012. Dennis was also the major shareholder and Chairman of the Central Healthcare group of companies which he developed in 2010 and which included CHS, a pharmacy wholesaling business, and PharmaSave, a retail pharmacy group. Dennis went on to sell the Central Healthcare group of companies to Sigma Pharmaceuticals in 2014.
Dennis is also currently the founder and Executive Chairman of myDNA – a world leading pharmacogenomic and health genomic platform company.
Executive leadership team
Chief Operating Officer
Andrew is a Chartered Accountant and has served alongside Dennis for more than 10 years, most recently as Arrow COO and following on the journey to DBG Health. Prior to this, he played a pivotal role in the success of both Central Healthcare Services and Ascent Pharmaceuticals in the role of COO and CFO respectively.
Alexander (Sandy) Mellis
Chief Commercial Officer
Sandy’s career has seen him develop and manage consumer health brands, and consumer goods markets in Australia, New Zealand, UK, US and more recently Europe. His 20+ years in the industry has provided Sandy with extensive experience in managing large multi-disciplinary teams, with multi-billion-dollar portfolios, across a variety of market channels.
Chief Legal Counsel
Sue began her legal career in the ABC Legal and Copyright Department. After being admitted to practice in 1999, she joined Herbert Geer and Rundle Lawyers and worked in the Media and Entertainment Group, acting for Village Roadshow, Austereo and the Mushroom Group. Sue moved into the pharmaceutical industry in 2007 when she joined Sigma Pharmaceuticals Limited as Corporate Counsel, moving into the position of General Counsel and Company Secretary in 2008. Sue left Sigma in 2015 to join Arrow Pharmaceuticals as GM Legal of the Arrow Group of Companies and is now Chief Legal Counsel of DBG Health.
Chief People Officer
Hamish is a Graduate of the Australian Institute of Company Directors and brings more than 15 years’ expertise in HR executive, retail and supply chain management working with Carter Holt Harvey, Wesfarmers (Coles Supermarkets and Kmart) and most recently, the National Disability Insurance Agency. In his early career, Hamish worked with Ernst and Young, gaining extensive experience leading large scale business transformation and change programs in Australia, New Zealand, US and Malaysia.
x, y, z*
* Based on Arrotex Pharmaceuticals and VidaCorp
** Based on DBG Health